01-11-2019 | Psoriatic arthritis | Podcast | Article

Discussing the guidelines for managing psoriatic arthritis: Part 2

Speakers: Dafna Gladman, Philip Mease, Oliver FitzGerald

In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF guidelines for the management of psoriatic arthritis, together with key clinical trials that have been published since the guidelines were released.

Transcript

Listen to part 1

Go to part 1

About the contributors

Dafna D Gladman

Dafna D Gladman is Professor of Medicine at the University of Toronto, Canada. Disclosures

Full biography

Philip Mease

Dr Mease is Clinical Professor of Medicine at the University of Washington, and directs the rheumatology research division at the Swedish Medical Center, Seattle. Disclosures

Read his full bio

Oliver FitzGerald

Oliver FitzGerald is a consultant rheumatologist and Newman Clinical Research Professor at St Vincent's University Hospital and the Conway Institute, University College Dublin. Disclosures

Read his full bio

Medicine Matters Rheumatology

Discussing the guidelines for managing psoriatic arthritis: Part 2

Listen to part 1

About the contributors

Dafna D Gladman

Philip Mease

Oliver FitzGerald

Related content

A closer look at guidelines for the management of PsA

ACR/NPF guidelines for the treatment of PsA published

Methotrexate versus etanercept as first-line therapy for psoriatic arthritis

Discussing the guidelines for managing psoriatic arthritis: Part 1

Medicine Matters Rheumatology

External Content

Listen to part 1

About the contributors

Dafna D Gladman

Philip Mease

Oliver FitzGerald

Related content

A closer look at guidelines for the management of PsA

ACR/NPF guidelines for the treatment of PsA published

Methotrexate versus etanercept as first-line therapy for psoriatic arthritis

Discussing the guidelines for managing psoriatic arthritis: Part 1